Global Oncology Research-Context Dashboard
A research-context overview of clinical activity, research output, and emerging cancer therapies — across every major region of the world.
This page presents an illustrative, educational overview of global cancer research, treatment innovation, clinical trial activity, and country-level oncology context, drawing on public research sources. It is a research-context overview, not a deployed real-time analytics service, and the figures shown are illustrative rather than live measurements.
Global Clinical Trial Activity
An illustrative overview of how global clinical trial activity is distributed across regions, phases, therapeutic classes, and sponsor types.
Figures on this page are illustrative examples for educational orientation, not live or exhaustive counts. For current records, consult ClinicalTrials.gov and the public research pages linked below.
4200
Trials (illustrative)
40%
Global Research Output (illustrative)
3800
Trials (illustrative)
35%
Global Research Output (illustrative)
2900
Trials (illustrative)
20%
Global Research Output (illustrative)
450
Trials (illustrative)
3%
Global Research Output (illustrative)
280
Trials (illustrative)
1.5%
Global Research Output (illustrative)
120
Trials (illustrative)
0.5%
Global Research Output (illustrative)
Global Therapeutics Pipeline Overview
An illustrative look at emerging cancer therapy classes from preclinical through Phase III development.
3200
Trials (illustrative)
450
Pipeline Drugs (illustrative)
2800
Trials (illustrative)
380
Pipeline Drugs (illustrative)
980
Trials (illustrative)
220
Pipeline Drugs (illustrative)
420
Trials (illustrative)
180
Pipeline Drugs (illustrative)
340
Trials (illustrative)
120
Pipeline Drugs (illustrative)
4760
Trials (illustrative)
560
Pipeline Drugs (illustrative)
EGFR
EGFR Mutation
KRAS
KRAS Mutation
BRCA1/BRCA2
BRCA1/BRCA2 Mutation
PD-L1
PD-L1 Expression
BRAF
BRAF V600E Mutation
TP53
TP53 Mutation
NTRK
NTRK Fusions
HER2
HER2 Amplification
Country Oncology Profiles
Explore research-context pages for cancer research, clinical trial activity, and cancer center networks in each country. Counts shown are illustrative.
United States
China
Japan
Germany
United Kingdom
France
Canada
Australia
South Korea
Sweden
Switzerland
Singapore
Institutions Active in Global Cancer Innovation
Illustrative examples of prominent research institutions; figures are not live counts.
USA
450
Trials (illustrative)
2800
Publications (illustrative)
USA
420
Trials (illustrative)
2600
Publications (illustrative)
USA
380
Trials (illustrative)
2400
Publications (illustrative)
Japan
320
Trials (illustrative)
1900
Publications (illustrative)
Sweden
290
Trials (illustrative)
1800
Publications (illustrative)
Australia
260
Trials (illustrative)
1600
Publications (illustrative)
France
240
Trials (illustrative)
1500
Publications (illustrative)
Germany
230
Trials (illustrative)
1700
Publications (illustrative)
Regulatory Context (Global)
An illustrative overview of activity across major health authorities. For current records, consult each authority's official announcements.
Nov 2024
Nov 2024
Oct 2024
Oct 2024
Nov 2024
Oct 2024
Where Oncology Research Is Heading (2025–2035)
An illustrative, non-exhaustive view of themes widely discussed in public oncology research.